U.S. flag

An official website of the United States government

Filters

See more specimen types...

Other countries

Results: 41 to 52 of 52

Tests names and labsConditionsGenes, analytes, and microbesMethods

Single gene testing AGPS

CeGaT GmbH
Germany
11
  • C Sequence analysis of the entire coding region

RHIZOMELIC CHONDRODYSPLASIA PUNCTATA TYPE 3

Laboratorio de Genetica Clinica SL
Spain
11
  • C Sequence analysis of the entire coding region

Chondrodysplasia punctata Panel

CeGaT GmbH
Germany
68
  • C Sequence analysis of the entire coding region

Potentially lethal skeletal disorders Panel

CeGaT GmbH
Germany
4544
  • C Sequence analysis of the entire coding region

AGPS Single Gene

Fulgent Genetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Skeletal Dysplasias NGS Panel

Fulgent Genetics
United States
543178
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Clinical Exome

Fulgent Genetics
United States
51284672
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Nuclear-Mito NGS Panel

Fulgent Genetics
United States
1103676
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Peroxisomal NGS Panel

Fulgent Genetics
United States
7621
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

MitoMet®Plus aCGH Analysis

Baylor Genetics
United States
842637
  • D Deletion/duplication analysis

Rhizomelic Chondrodysplasia Punctata Type 3

Amsterdam UMC, Location AMC Laboratory Genetic Metabolic Diseases, LGMD
Netherlands
11
  • E Enzyme assay
  • C Sequence analysis of the entire coding region

Rhizomelic Chondrodysplasia Punctatas

Braverman Laboratory Research Institute of the McGill University Health Center
Canada
56
  • C Sequence analysis of the entire coding region

Results: 41 to 52 of 52

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.